Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company discovering and developing new ...

The account director discusses the big challenges for marketing in the world of healthcare, including budgets, inclusivity ...

Zlata Pharma LLP hosted a memorable event to mark the launch of its new wellness product range, marking a significant ...

“In 2025, expect AI, fueled by new GenAI-enabled capabilities, to chip away at gains in efficiency, accuracy, and speed ...

Eric Peacock, co-founder and CEO of MyHealthTeam, framed the merger as beneficial for patients, too, saying in a statement ...

JM Financial predicts 5.8% YoY profit growth in 3QFY25, driven by IT services and pharmaceuticals, despite challenges in BFSI ...

What I've learned from my work in this field is that having a well-crafted commercial strategy is important for companies ...

West Pharmaceutical Services (WST) stock is down 16% due to deteriorating fundamentals, with emphasis on future growth ...

Buprenorphine is indicated for the substitution treatment of opioid drug dependence. According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD ...

Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.

Here are 15 more compelling datapoints about the state of healthcare and pharma marketing: 32: The percentage of laid off ...